Related Experiment Videos

[From diagnostic and therapeutic guidelines to clinical practice in Brazil]

Fábio Vilas-Boas1

  • 1Presidente do Grupo de Estudos em Insuficiência Cardíaca Sociedade Brasileira de Cardiologia, Salvador, Brasil. fabiovboas@hospitalalianca.com.br

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|November 6, 2004
PubMed

Insights

Heart failure (HF) affects millions globally, with Brazil seeing significant hospital admissions. Socioeconomic disparities impact treatment adherence and outcomes in heart failure patients.

Area of Science:

  • Cardiology and Public Health

Context:

  • Heart failure (HF) is a global health concern with high incidence and prevalence.
  • Increased life expectancy due to improved treatments results in a higher prevalence of HF in the community.
  • In Brazil, HF accounts for 4% of all hospitalizations and 31% of cardiovascular disease hospitalizations.

Purpose:

  • To analyze the current landscape of heart failure management in Brazil.
  • To highlight the adherence to Brazilian Society of Cardiology Guidelines on Heart Failure.
  • To identify challenges in HF treatment compliance, particularly socioeconomic disparities.

Summary:

  • Brazilian cardiologists largely follow international guidelines for chronic heart failure (HF) management.
  • Therapeutic options aim to slow ventricular remodeling and reduce mortality.
  • Disparities between public and private healthcare systems impede patient compliance, especially in lower social classes.

Impact:

  • Understanding these disparities is crucial for improving HF patient outcomes in Brazil.
  • The findings can inform public health policies to enhance equitable access to HF care.
  • Addressing socioeconomic barriers is essential for optimizing the efficacy of heart failure treatments.

Related Concept Videos

Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...